We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy.
- Authors
Cella, David; Viswanathan, Hema N.; Hays, Ron D.; Mendoza, Tito R.; Stein, Kevin D.; Pasta, David J.; Foreman, Aimee J.; Vadhan-Raj, Saroj; Kahllich, Joel D.; Kallich, Joel D
- Abstract
<bold>Background: </bold>This study was conducted to develop a brief measure of fatigue and functional impact in cancer patients with anemia.<bold>Methods: </bold>Data were obtained from a multisite, phase 2 study of darbepoetin-alpha (n = 1,558). Eligible patients were >or=18 years with nonmyeloid malignancies and anemia (hemoglobin <or=11 g/dL) who were receiving chemotherapy. Items from the Functional Assessment of Cancer Therapy-Fatigue (FACT-F), Brief Fatigue Inventory (BFI), Fatigue Symptom Inventory (FSI), and items adapted from the Medical Outcomes Study SF-36 physical functioning scale were evaluated for inclusion in the measure. Items were selected by identifying the best predictors of total FACT-F scores, hemoglobin, and adjusted maximum oxygen uptake (VO(2)Max) in regression models. Correlations were examined between scale scores and adjusted VO(2)Max, hemoglobin, performance status, self-reported energy, and productivity.<bold>Results: </bold>Data from 401 patients with complete data were used to identify 8 items for the Fatigue and Functional Impact Scale (FFIS), which was then evaluated using 1,355 of the 1,558 patients. The FFIS had an estimated internal consistency reliability of 0.90. The FFIS had significant correlations with the FACT-F (r = 0.94), FSI (r = 0.80), and BFI (r = 0.86), from which it was derived. The FFIS also correlated substantially with single-item measures of energy (r = 0.75) and productivity (r = 0.72).<bold>Conclusions: </bold>The FFIS is a reliable, brief, and practical tool that is potentially suitable for identifying fatigue and functional impact in cancer patients.
- Subjects
DRUG therapy; CANCER patients; ANEMIA; MENTAL health; QUALITY of life; FATIGUE (Physiology); ONCOLOGY research; HEMATOPOIETIC agents; COMPARATIVE studies; ERYTHROPOIETIN; HEALTH surveys; RESEARCH methodology; MEDICAL cooperation; RESEARCH; RESEARCH funding; SICKNESS Impact Profile; TUMORS; EVALUATION research; PREDICTIVE tests; DISEASE complications; DIAGNOSIS; THERAPEUTICS
- Publication
Cancer (0008543X), 2008, Vol 113, Issue 6, p1480
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/cncr.23698